Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)

Who May Qualify: - Diagnosis of mild to moderate open-angle glaucoma or ocular hypertension - Planned removal of cataract - Female participants of childbearing potential must have a negative urine pregnancy test at the baseline visit and agree to the use of contraception Who Should NOT Join This Trial: - Uncontrolled systemic disease - History of incisional/refractive corneal surgery - Any glaucoma diagnosis other than OHT, open-angle, pseudoexfoliative, or pigmentary glaucoma - History of incisional glaucoma surgery or intraocular injections - Other ocular diseases, pathology, or conditions Always talk to your doctor about whether this trial is right for you.